IPCI
IntelliPharmaCeutics International Inc.
NasdaqCM
People also watch:IDRACPRXCLSNIMUCIGXT
1.720.02 (1.18%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close1.70
Open1.70
Bid1.50 x 500
Ask3.50 x 500
52wk Range1.41 - 3.54
Day's Range1.69 - 1.76
Volume172,673
Avg Vol (3m)125,625
As of 4:00 PM EDT. Market closed.
  • Associated Press16 days ago

    Intellipharmaceutics reports 2Q loss

    On a per-share basis, the Toronto-based company said it had a loss of 8 cents. The extended-release drug developer posted revenue of $556,000 in the period. The company's shares closed at $1.62. A year ...

  • Here’s What You Need to Know About IntelliPharmaCeutics Intl Inc (USA) (IPCI)
    Insider Monkey21 days ago

    Here’s What You Need to Know About IntelliPharmaCeutics Intl Inc (USA) (IPCI)

    IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) is a tiny Canadian biotech with no approved products and a market capitalization of a little over $40 million at last count. It generates virtually no revenues, and its entire cash holding derives from a $5.2 million public offering that closed at the beginning of last month. It’s down close to […]